EurekaMag.com logo
+ Translate

Polymorphism and malaria vaccines


, : Polymorphism and malaria vaccines. Parasitology Today 6(3): 76

The correspondent comments on the paper by D. Arnot on antigenic polymorphism in Plasmodium (Parasitology Today (1990) 6 (3), 64-65) and the interpretation of the author's data on polymorphism in T-cell epitopes of the circumsporozoite protein.

Accession: 001912862

PMID: 15463302

DOI: 10.1016/0169-4758(90)90213-n

Download PDF Full Text: Polymorphism and malaria vaccines


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Anonymous, 2014: New malaria vaccines roadmap targets next generation products by 2030. Partners agree approach for developing vaccines capable of reducing malaria cases by 75%, and to enable malaria elimination. Central European Journal of Public Health 21(4): 206-206

Arnot, D.E., 1990: Polymorphism in the circumsporozoite protein and anti-sporozoite malaria vaccines. The problems posed by antigenic polymorphism in the circumsporozoite protein to the development of malaria vaccines are discussed with reference to 2 recent papers (Rosenberg, R. et al., Science (1989) 245, 973-976 and Lockyer, M.J. et al., Molecu...

Halloran, M.E.; Struchiner, C.J.; Spielman, A., 1989: Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. Population effects of malaria vaccination programs will depend on the stage specificity of the vaccine, its duration of effectiveness, whether it is responsive to natural boosting, the proportion vaccinated, and the preexisting endemic conditions....

Levine, M.M.; Herrington, D.; Clyde, D.; Murphy, J.; Davis, J.; Nussenzweig, R.; Nardin, E.; Felix, A.; Heimer, E.; Gillesen, D., 1988: Malaria vaccines: experience with sporozoite vaccines against falciparum malaria. Recent advances in the development of a sporozoite vaccine for malaria are summarized.

Wilson, K.L.; Xiang, S.D.; Plebanski, M., 2016: A Model to Study the Impact of Polymorphism Driven Liver-Stage Immune Evasion by Malaria Parasites, to Help Design Effective Cross-Reactive Vaccines. Malaria parasites engage a multitude of strategies to evade the immune system of the host, including the generation of polymorphic T cell epitope sequences, termed altered peptide ligands (APLs). Herein we use an animal model to study how single a...

Duffy, P.E.; Krzych, U.; Francis, S.; Fried, M., 2005: Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum. Naturally acquired immunity and immunity acquired after immunization with attenuated parasites indicate that a vaccine against malaria is feasible. Several obstacles have stymied malaria vaccine development, among them our poor understanding of pr...

Constable, L., 2012: Investment in malaria research has led to strong pipeline of malaria vaccines, report suggests. Expert Review of Vaccines 10(8): 1116-1116

Plowe, C.V.; Alonso, P.; Hoffman, S.L., 2009: The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. Journal of Infectious Diseases 200(11): 1646-1649

Grau, G.E.; Del Giudice, G.; Lambert, P.H., 1987: Host immune response and pathological expression in malaria: possible implications for malaria vaccines. This review of malaria covers the genetic background of the host in regulating the intensity of the immune response against the epitope of Plasmodium falciparum circumsporozoite protein plus the involvement of immune mechanisms in some complicatio...

Chilengi, R., 2009: Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?. Clinical development of malaria vaccines has had remarkable achievements in the past decade, but an efficacious vaccine is yet to be licensed. There are many scientific and technical challenges that hamper progress ranging from parasite to host to...